This will be the second trip to the Supreme Court for the Myriad case, which the high court sent back to the Court of Appeals for the Federal Circuit in Washington in March for reconsideration after it issued a decision narrowing the scope of allowable patents.
FORBES: Supreme Court To Decide If Human Genes Can Be Patented In Myriad Case